Oberweis Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.2M Buy
219,930
+102,350
+87% +$7.22M 0.42% 94
2025
Q4
$7.91M Hold
117,580
0.29% 124
2025
Q3
$8.62M Sell
117,580
-64,620
-35% -$4.29M 0.33% 113
2025
Q2
$9.48M Buy
+182,200
New +$10.4M 0.41% 89
2024
Q1
Sell
-96,300
Closed -$3.56M 204
2023
Q4
$3.56M Buy
96,300
+45,800
+91% +$1.72M 0.33% 119
2023
Q3
$1.93M Buy
+50,500
New +$2.07M 0.2% 161
2023
Q2
Sell
-164,040
Closed -$6.26M 190
2023
Q1
$6.26M Buy
164,040
+20,650
+14% +$969K 0.97% 17
2022
Q4
$8.16M Buy
143,390
+26,850
+23% +$1.37M 1.73% 10
2022
Q3
$4.61M Buy
116,540
+13,490
+13% +$596K 1.08% 14
2022
Q2
$4.53M Sell
103,050
-4,400
-4% -$190K 1.15% 12
2022
Q1
$4.29M Buy
107,450
+1,800
+2% +$64.1K 0.86% 17
2021
Q4
$4.25M Buy
105,650
+35,670
+51% +$1.33M 0.78% 22
2021
Q3
$2.85M Buy
69,980
+780
+1% +$32.6K 0.59% 23
2021
Q2
$3.14M Buy
69,200
+300
+0.4% +$13.3K 0.69% 22
2021
Q1
$2.87M Buy
+68,900
New +$3.15M 0.59% 26

Other funds holding HALO

Oberweis Asset Management's HALO Position: Q1 2026 in Review

Oberweis Asset Management increased its Halozyme (HALO) stake by 87% in Q1 2026, buying an estimated $7.22M and bringing the position to 219,930 shares worth $14.2M. The position accounts for 0.42% of the portfolio, ranked #94.

Oberweis Asset Management first reported a position in HALO in Q1 2021 and has held it in 15 quarters since. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Oberweis Asset Management held 219,930 shares of Halozyme worth $14.2M as of Q1 2026.
  • Oberweis Asset Management bought 102,350 Halozyme shares in Q1 2026, an estimated $7.22M.
  • Halozyme made up 0.42% of Oberweis Asset Management's portfolio in Q1 2026, its #94 holding.
  • Oberweis Asset Management first reported a position in Halozyme in Q1 2021 and has held it in 15 quarters since.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Oberweis Asset Management's 13F filing for Q1 2026, filed 15 May 2026.